secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-07-23T00:13:48+00:00
Accession:  0001829126-26-007760
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO files prospectus supplement for securities offering
------------------------------------------------------------

- Filed prospectus supplement under Rule 424(b) on July 22, 2026 for an offering of securities.
- Offering made under effective S-3 registration statement (File No. 333-295667).
- Legal opinion from Haynes and Boone, LLP on validity of securities included as Exhibit 5.1.
- No specific terms (size, price, type) of the offering disclosed in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626007760/0001829126-26-007760-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626007760/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-007760

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer